ClinicalTrials.Veeva

Menu
S

Suncoast Research Associates, LLC | Miami, FL

Research site

Site insights

Top conditions

Top treatments

PF-04965842
PF04965842
Desvenlafaxine
Linzagolix
Escitalopram
VX-993
Gabapentin
Suzetrigine
Pregabalin
Paroxetine

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Melissa Rodriguez

Verified by this site

Active trials

7 of 38 total trials

A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation (LIBREXIA-AF)

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-cent...

Active, not recruiting
Atrial Fibrillation
Drug: Apixaban Placebo
Drug: Milvexian

The primary objective of the study is to determine the relative efficacy of the investigational oral severe acute respiratory syndrome coronavirus 2...

Active, not recruiting
COVID-19
SARS-CoV2
Biological: VXA-CoV2-3.1
Biological: VXA-CoV2-3.3

The primary objectives of this study are to evaluate the safety and reactogenicity of mRNA-1403, and to demonstrate the efficacy of mRNA-1403 to prev...

Active, not recruiting
Acute Gastroenteritis
Norovirus Acute Gastroenteritis
Biological: mRNA-1403
Biological: Placebo
Locations recently updated

The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabet...

Enrolling
Diabetic Peripheral Neuropathic Pain
Drug: Suzetrigine
Drug: Placebo (matched to Pregabalin)

The purpose of this study is to evaluate the efficacy, safety, and tolerability of VX-993 in participants with pain associated with Diabetic Peripher...

Enrolling
Diabetic Peripheral Neuropathic Pain
Drug: Placebo (matched to pregabalin)
Drug: Placebo (matched to VX-993)

The purpose of this phase 3 multicenter, randomized, double-blind, placebo-controlled rollover study is to evaluate the safety and long-term immunoge...

Active, not recruiting
Chikungunya Virus Infection
Biological: Placebo booster
Biological: CHIKV VLP vaccine booster

The aim of this study is to evaluate the safety and immunogenicity of a human metapneumovirus (hMPV) / respiratory syncytial virus (RSV) mRNA vaccine...

Active, not recruiting
Human Metapneumovirus Immunization
Respiratory Syncytial Virus Immunization
Biological: Placebo
Biological: Investigational hMPV vaccine (monovalent)

Trial sponsors

Moderna logo
Sanofi logo
Bavarian Nordic logo
Merck Sharp & Dohme (MSD) logo
Pfizer logo
Vertex Pharmaceuticals logo
Janssen (J&J Innovative Medicine) logo
Janssen (J&J Innovative Medicine) logo
Novavax logo
Astellas logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems